Catalyst Wire Dossier Catalyst Wire Dossier

CnU Capsule 750 mg

CnU · Myungmoon Pharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CnU Capsule 750 mg, covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones). [Phase 4]

See pricing